Your browser doesn't support javascript.
loading
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
Dai, Hanren; Wu, Zhiqiang; Jia, Hejin; Tong, Chuan; Guo, Yelei; Ti, Dongdong; Han, Xiao; Liu, Yang; Zhang, Wenying; Wang, Chunmeng; Zhang, Yajing; Chen, Meixia; Yang, Qingming; Wang, Yao; Han, Weidong.
Afiliação
  • Dai H; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Wu Z; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Jia H; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China.
  • Tong C; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Guo Y; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Ti D; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Han X; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Liu Y; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Zhang W; Department of Molecular Biology and Immunology, Institute of Basic Medicine, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Wang C; Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing, China.
  • Zhang Y; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Chen M; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Yang Q; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Wang Y; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
  • Han W; Department of Bio-therapeutic, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
J Hematol Oncol ; 13(1): 30, 2020 04 03.
Article em En | MEDLINE | ID: mdl-32245502
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Antígenos CD19 / Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Antígenos CD19 / Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article